Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Bristol-Myers Squibb and Somerset sign agreement for Emsam

Dec. 28, 2004

Actelion begins global phase IIb/III program for clazosentan

Dec. 28, 2004

GW receives Qualifying Notice for Sativex in Canada

Dec. 28, 2004

Amgen and Array BioPharma collaboration yields novel antiinflammatory agents

Dec. 27, 2004

Topiramate shows promise in the control of aggression

Dec. 27, 2004

Glutamate receptor modulators described in patent literature

Dec. 23, 2004

New phase IIa study for ATL-1102 in MS

Dec. 23, 2004

sNDA filing for Attenace for ADHD

Dec. 23, 2004

Concern over cardiovascular risk of naproxen

Dec. 23, 2004

New head-to-head study compares Tysabri to Rebif

Dec. 23, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...